Form 4: Arteris Inc. Director Wayne C. Cantwell Sells Shares Under 10b5-1 Trading Plan

Director Wayne C. Cantwell of Arteris Inc. sold a total of 5,000 shares of common stock over two days under a pre-arranged 10b5-1 trading plan.

Summary

• Wayne C. Cantwell, a director at Arteris Inc., sold 2,400 shares of common stock on December 11, 2024, at a weighted average price of $10.0067 per share.
• He then sold an additional 2,600 shares on December 12, 2024, at a weighted average price of $10.0297 per share.
• These transactions were executed under a 10b5-1 trading plan adopted on June 7, 2024.
• Following these sales, Cantwell directly owns 238,198 shares and indirectly owns 38,761 shares through the Decathlon Capital Management 401K Plan.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by a director under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine disclosure of stock sales by a company director, which is common practice and does not necessarily indicate a change in the company's outlook.

Comparison to Industry Standards

• Directors selling shares under 10b5-1 plans is a common practice across publicly traded companies, including those in the technology sector like Arteris.
• These plans allow insiders to sell shares without being accused of trading on non-public information.
• The volume of shares sold is relatively small compared to the total outstanding shares of the company, which is typical for such transactions.

Stakeholder Impact

• The stock sales by a director may have a minor impact on the share price, but the effect is likely to be minimal due to the relatively small volume of shares sold.

Key Dates

Keywords

Arteris Inc., Wayne C. Cantwell, stock sale, 10b5-1 trading plan, insider trading, director, share transaction